�����

Public-private partnerships are highly beneficial as they leverage on the strengths of both sides to advance genomic science and medicine in Singapore- and help create successful local biotech companies.

This was the view of Genome Institute of �����Executive Director- Professor Ng Huck Hui- as he commented on the recent tie-up between GIS and NovogeneAIT Genomics. The latter is a joint venture between Novogene- a leading commercial provider of genomic services and solution and a local biotechnology company- AITbiotech.

GIS and NovogeneAIT Genomics have agreed to establish a joint whole genome sequencing (WGS) centre at Biopolis. The partners will devote a major portion of the centre’s sequencing capabilities to support public research projects and empower super scale sequencing initiatives in �����and the region. NovogeneAIT will also work with GIS to develop new applications of next-generation sequencing- such as WGS solutions for cancer diagnosis and stratified cancer treatment.

Novogene CEO Dr Ruiqiang Li said: “The centre is the first major project for NovogeneAIT and is an important milestone for our company. This unique partnership allows us to work with the �����and regional communities on large scale sequencing projects. This new base also provides exciting opportunities for local research initiatives that can benefit humanity.”